Option Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by Blue Trust Inc.

Blue Trust Inc. boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 16.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,703 shares of the company’s stock after purchasing an additional 681 shares during the quarter. Blue Trust Inc.’s holdings in Option Care Health were worth $109,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Wellington Management Group LLP boosted its holdings in shares of Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after buying an additional 1,328,326 shares in the last quarter. FMR LLC boosted its stake in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares in the last quarter. Westfield Capital Management Co. LP grew its holdings in shares of Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares during the last quarter. State Street Corp grew its holdings in shares of Option Care Health by 1.4% during the third quarter. State Street Corp now owns 6,257,172 shares of the company’s stock worth $195,849,000 after purchasing an additional 83,395 shares during the last quarter. Finally, Thrivent Financial for Lutherans increased its position in shares of Option Care Health by 7.4% during the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after purchasing an additional 404,811 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

Shares of OPCH stock opened at $30.82 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a 50 day simple moving average of $25.75 and a 200-day simple moving average of $27.90. The company has a market cap of $5.24 billion, a price-to-earnings ratio of 25.90, a price-to-earnings-growth ratio of 2.19 and a beta of 1.35. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.